￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Can lung squamous cell carcinoma without mutations be treated with afatinib?

2025-10-19 11:44:20

Check Details
Is afatinib a second-line treatment for lung squamous cell carcinoma?

2025-10-19 11:44:20

Check Details
The efficacy of nivolumab combined with ipilimumab in the treatment of non-small cell lung cancer

2025-10-19 11:44:20

Check Details
What patients with lung cancer need to know about using larotrectinib

2025-10-19 11:44:20

Check Details
Afatinib is the first oral targeted drug for lung squamous cell carcinoma approved by the FDA_ Kanghule

2025-10-19 11:44:20

Check Details
The broad-spectrum anti-tumor drug larotrectinib is applicable to the population, usage and dosage

2025-10-19 11:44:20

Check Details
How effective is nivolumab in the treatment of advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Afatinib can effectively improve the survival of patients with lung squamous cell carcinoma_ Kanghule

2025-10-19 11:44:20

Check Details
How long can one live after gefitinib is used to treat non-small cell lung cancer?

2025-10-19 11:44:20

Check Details
Can nivolumab alone be used to treat lung cancer

2025-10-19 11:44:20

Check Details
How long does it take to develop resistance to the anti-cancer drug larotrectinib?

2025-10-19 11:44:20

Check Details
Median survival time of cabozantinib in lung cancer treatment

2025-10-19 11:44:20

Check Details
Category
相关知识